Botulinum Toxin for Urinary Tract Disease: After a Decade from Approval

Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector?

• Format: Hardcover
• Language: English
• ISBN: 3725863385
• ISBN13: 9783725863389
• Release Date: January 2026
• Publisher: Mdpi AG
• Length: 138 Pages
• Weight: 1.10 lbs.
• Dimensions: 0.5" x 6.7" x 9.6"